221 related articles for article (PubMed ID: 28196856)
21. miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells.
Kumar P; Bhattacharyya S; Peters KW; Glover ML; Sen A; Cox RT; Kundu S; Caohuy H; Frizzell RA; Pollard HB; Biswas R
Gene Ther; 2015 Nov; 22(11):908-16. PubMed ID: 26133785
[TBL] [Abstract][Full Text] [Related]
22. Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation.
Ferrari E; Monzani R; Villella VR; Esposito S; Saluzzo F; Rossin F; D'Eletto M; Tosco A; De Gregorio F; Izzo V; Maiuri MC; Kroemer G; Raia V; Maiuri L
Cell Death Dis; 2017 Jan; 8(1):e2544. PubMed ID: 28079883
[TBL] [Abstract][Full Text] [Related]
23. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.
Deschemin JC; Allouche S; Brouillard F; Vaulont S
PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821
[TBL] [Abstract][Full Text] [Related]
24. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931.
Veltman M; Stolarczyk M; Radzioch D; Wojewodka G; De Sanctis JB; Dik WA; Dzyubachyk O; Oravecz T; de Kleer I; Scholte BJ
Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L1000-L1014. PubMed ID: 27663991
[TBL] [Abstract][Full Text] [Related]
25. Regulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages.
Kostyk AG; Dahl KM; Wynes MW; Whittaker LA; Weiss DJ; Loi R; Riches DW
Am J Pathol; 2006 Jul; 169(1):12-20. PubMed ID: 16816357
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis.
Delion M; Braux J; Jourdain ML; Guillaume C; Bour C; Gangloff S; Pimpec-Barthes FL; Sermet-Gaudelus I; Jacquot J; Velard F
J Pathol; 2016 Sep; 240(1):50-60. PubMed ID: 27235726
[TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis.
Tarique AA; Evron T; Zhang G; Tepper MA; Morshed MM; Andersen ISG; Begum N; Sly PD; Fantino E
J Cyst Fibros; 2020 Sep; 19(5):823-829. PubMed ID: 32387042
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of endothelial cell dysfunction in cystic fibrosis.
Totani L; Plebani R; Piccoli A; Di Silvestre S; Lanuti P; Recchiuti A; Cianci E; Dell'Elba G; Sacchetti S; Patruno S; Guarnieri S; Mariggiò MA; Mari VC; Anile M; Venuta F; Del Porto P; Moretti P; Prioletta M; Mucilli F; Marchisio M; Pandolfi A; Evangelista V; Romano M
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3243-3253. PubMed ID: 28847515
[TBL] [Abstract][Full Text] [Related]
29. Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages.
Deriy LV; Gomez EA; Zhang G; Beacham DW; Hopson JA; Gallan AJ; Shevchenko PD; Bindokas VP; Nelson DJ
J Biol Chem; 2009 Dec; 284(51):35926-38. PubMed ID: 19837664
[TBL] [Abstract][Full Text] [Related]
30. F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis.
Martins JR; Kongsuphol P; Sammels E; Dahimène S; Aldehni F; Clarke LA; Schreiber R; de Smedt H; Amaral MD; Kunzelmann K
Biochim Biophys Acta; 2011 Nov; 1812(11):1385-92. PubMed ID: 21907281
[TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis transmembrane conductance regulator in human muscle: Dysfunction causes abnormal metabolic recovery in exercise.
Lamhonwah AM; Bear CE; Huan LJ; Kim Chiaw P; Ackerley CA; Tein I
Ann Neurol; 2010 Jun; 67(6):802-8. PubMed ID: 20517942
[TBL] [Abstract][Full Text] [Related]
32. Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages.
Aridgides DS; Mellinger DL; Gwilt LL; Hampton TH; Mould DL; Hogan DA; Ashare A
Sci Rep; 2023 Jul; 13(1):11995. PubMed ID: 37491532
[TBL] [Abstract][Full Text] [Related]
33. CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis.
Tarique AA; Sly PD; Holt PG; Bosco A; Ware RS; Logan J; Bell SC; Wainwright CE; Fantino E
J Cyst Fibros; 2017 Jul; 16(4):475-482. PubMed ID: 28428011
[TBL] [Abstract][Full Text] [Related]
34. Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Chung WJ; Goeckeler-Fried JL; Havasi V; Chiang A; Rowe SM; Plyler ZE; Hong JS; Mazur M; Piazza GA; Keeton AB; White EL; Rasmussen L; Weissman AM; Denny RA; Brodsky JL; Sorscher EJ
PLoS One; 2016; 11(10):e0163615. PubMed ID: 27732613
[TBL] [Abstract][Full Text] [Related]
35. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
Roxo-Rosa M; Xu Z; Schmidt A; Neto M; Cai Z; Soares CM; Sheppard DN; Amaral MD
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17891-6. PubMed ID: 17098864
[TBL] [Abstract][Full Text] [Related]
36. In vivo monitoring of lung inflammation in CFTR-deficient mice.
Stellari F; Bergamini G; Ruscitti F; Sandri A; Ravanetti F; Donofrio G; Boschi F; Villetti G; Sorio C; Assael BM; Melotti P; Lleo MM
J Transl Med; 2016 Jul; 14(1):226. PubMed ID: 27468800
[TBL] [Abstract][Full Text] [Related]
37. Salmeterol restores secretory functions in cystic fibrosis airway submucosal gland serous cells.
Delavoie F; Molinari M; Milliot M; Zahm JM; Coraux C; Michel J; Balossier G
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):388-97. PubMed ID: 18931328
[TBL] [Abstract][Full Text] [Related]
38. HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR.
Moniz S; Sousa M; Moraes BJ; Mendes AI; Palma M; Barreto C; Fragata JI; Amaral MD; Matos P
ACS Chem Biol; 2013 Feb; 8(2):432-42. PubMed ID: 23148778
[TBL] [Abstract][Full Text] [Related]
39. The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation.
Le Henaff C; Gimenez A; Haÿ E; Marty C; Marie P; Jacquot J
Am J Pathol; 2012 May; 180(5):2068-75. PubMed ID: 22449949
[TBL] [Abstract][Full Text] [Related]
40. Inflammation in cystic fibrosis: An update.
Roesch EA; Nichols DP; Chmiel JF
Pediatr Pulmonol; 2018 Nov; 53(S3):S30-S50. PubMed ID: 29999593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
